Short Interest in Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Drops By 56.3%

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the recipient of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a drop of 56.3% from the October 15th total of 1,600 shares. Based on an average trading volume of 4,600 shares, the days-to-cover ratio is presently 0.2 days.

Relief Therapeutics Trading Up 0.9 %

Shares of OTCMKTS:RLFTF traded up $0.07 during midday trading on Wednesday, hitting $7.27. The company’s stock had a trading volume of 1,274 shares, compared to its average volume of 2,840. The stock’s 50 day simple moving average is $4.78 and its 200 day simple moving average is $2.55. Relief Therapeutics has a fifty-two week low of $1.10 and a fifty-two week high of $7.60.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.